Thiazolidinediones prevent PDGF-BB-induced CREB depletion in pulmonary artery smooth muscle cells by preventing upregulation of casein kinase 2 alpha' catalytic subunit.
Thiazolidinediones prevent PDGF-BB-induced CREB depletion in pulmonary artery smooth muscle cells by preventing upregulation of casein kinase 2 alpha' catalytic subunit.
复制标题
DOI:
10.1097/fjc.0b013e3181d64dbe
复制
发表时间:
2010-05
影响因子:
3
通讯作者:
Klemm DJ
中科院分区:
文献类型:
--
作者:
Garat CV;Crossno JT Jr;Sullivan TM;Reusch JE;Klemm DJ
The transcription factor CREB is diminished in smooth muscle cells (SMCs) in remodeled, hypertensive pulmonary arteries (PAs) in animals exposed to chronic hypoxia. Forced depletion of CREB in PA SMCs stimulates their proliferation and migration in vitro. PDGF produced in the hypoxic PA wall promotes CREB proteasomal degradation in SMCs via PI3Kinase/Akt signaling, which promotes phosphorylation of CREB at two casein kinase 2 (CK2) sites. Here we tested whether thiazolidinediones, agents that inhibit hypoxia-induced PA remodeling, attenuate SMC CREB loss. We found that the thiazolidinedione rosiglitazone prevented PA remodeling and SMC CREB loss in rats exposed to chronic hypoxia. Likewise, the thiazolidinedione troglitazone blocked PA SMC proliferation and CREB depletion induced by PDGF in vitro. Thiazolidinediones did not repress Akt activation by hypoxia in vivo or by PDGF in vitro. However, PDGF induced CK2 α′ catalytic subunit expression and activity in PA SMCs, and depletion of CK2 α′ subunit prevented PDGF-stimulated CREB loss. Troglitazone inhibited PDGF-induced CK2 α′ subunit expression in vitro and rosiglitazone blocked induction of CK2 catalytic subunit expression by hypoxia in PA SMCs in vivo. We conclude that thiazolidine-diones prevent PA remodeling in part by suppressing upregulation of CK2 and loss of CREB in PA SMCs.